Forskning ved Københavns Universitet - Københavns Universitet

Forside

Impact of baseline renal function on the efficacy and safety of aliskiren added to losartan in patients with type 2 diabetes and nephropathy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Frederik Persson
  • Julia B Lewis
  • Edmund J Lewis
  • Peter Rossing
  • Norman K Hollenberg
  • Hans-Henrik Parving
  • AVOID Study Investigators
Proteinuric diabetic patients with reduced glomerular filtration rate (GFR) are at high risk of renal and cardiovascular disease progression and treatment-related adverse events. This post hoc analysis assessed the efficacy and safety of aliskiren added to the maximal recommended dose of losartan according to baseline estimated GFR (eGFR) (stage 1-3 chronic kidney disease [CKD]).
OriginalsprogEngelsk
TidsskriftDiabetes Care
Vol/bind33
Udgave nummer11
Sider (fra-til)2304-9
Antal sider6
ISSN0149-5992
DOI
StatusUdgivet - 1 nov. 2010

ID: 34163192